Production and Quality Control of High-Capacity Adenoviral Vectors

Cell Biology, Four-Volume Set

Volumn 1, Issue , 2006, Pages 445-456

  Schiedner, Gudrun ^a   Kreppel, Florian ^b   Kochanek, Stefan ^b  

^a CEVEC Pharmaceuticals GmbH   (Germany)

^b UNIVERSITY OF ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84884880688     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012164730-8/50055-1     Document Type: Chapter

References (17)

1. Fallaux F.J., Bout A., van der Velde I., van den Wollenberg D.J., Hehir K.M., Keegan J., Auger C., Cramer S.J., van Ormondt H., van der Eb A.J., Valerio D., Hoeben R.C. New helper cells and matched early region 1-deleted adenovirus vectors prevent generation of replication-competent adenoviruses. Hum. Gene Ther. 1998, 9:1909-1917.
2. Gao G.P., Engdahl R.K., Wilson J.M. A cell line for high-yield production of E1-deleted adenovirus vectors without the emergence of replication-competent virus. Hum. Gene Ther. 2000, 11:213-219.
3. Graham F.L., Smiley J., Russel W.C., Nairn R. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 1977, 36:59-74.
4. Hartigan-O'Connor D., Barjot C., Crawford R., Chamberlain J.S. Efficient rescue of gutted adenovirus genomes allows rapid production of concentrated stocks without negative selection. Hum. Gene Ther. 2002, 13:519-531.
5. Hilgenberg M., Schnieders F., Löser P., Strauss M. System for efficient helper-dependent minimal adenovirus construction and rescue. Hum. Gene. Ther. 2001, 12:643-657.
6. Kreppel, F., Biermann, V., Kochanek, S., and Schiedner, G. A DNA-based method to assay total and infectious particle contents and helper virus contamination in high-capacity adenoviral vector preparations. Hum. Gene Ther.13, 1151-1156.
7. Ng P., Beauchamp C., Evelegh C., Parks R., Graham F.L. Development of a FLP/frt system for generating helper-dependent adenoviral vectors. Mol. Ther. 2001, 3:809-815.
8. Palmer D., Ng P. Improved system for helper-dependent adenoviral vector production. Mol. Ther. 2003, 11:504-511.
9. Parks R.J., Bramson J.L., Wan Y., Addison C.L., Graham F.L. Effects of stuffer DNA on transgene expression from helper-dependent adenovirus vectors. J. Virol. 1999, 73:8027-8034.
10. Parks R.J., Chen L., Anton M., Sankar U., Rudnicki M.A., Graham F.L. A helper-dependent adenovirus vector system: Removal of helper virus by Cre-mediated excision of the viral packaging signal. Proc. Natl. Acad. Sci. USA 1996, 93:13,565-13,570.
11. Parks R.J., Graham F.L. A helper-dependent system for adenovirus vector production helps define a lower limit for efficient DNA packaging. J. Virol. 1997, 7:3293-3298.
12. Sakhuja K., Reddy P.S., Ganesh S., Cantaniag F., Pattison S., Limbach P., Kayda D.B., Kadan M.J., Kaleko M., Connelly S. Optimization of the generation and propagation of gutless adenoviral vectors. Hum. Gene Ther. 2003, 14:243-254.
13. Sandig V., Youil R., Bett A.J., Franlin L.L., Oshima M., Maione D., Wang F., Metzker M.L., Savino R., Caskey C.T. Optimization of the helper-dependent adenovirus system for production and potency in vivo. Proc. Natl. Acad. Sci. USA 2000, 97:1002-1007.
14. Schiedner G., Hertel S., Kochanek S. Efficient transformation of primary human amniocytes by E1 functions if Ad5: Generation of new cell lines for adenoviral vector production. Hum. Gene Ther. 2000, 11:2105-2116.
15. Schmid S.I., Hearing P. Cellular components interact with adenovirus type 5 minimal DNA packaging domains. J. Virol. 1998, 72:6339-6347.
16. Thomas C.E., Schiedner G., Kochanek S., Castro M.G., Löwenstein P.R. Peripheral infection with adenovirus causes unexpected long-term brain inflammation in animals injected intracranially with first-generation, but not with high-capacity, adenovirus vectors: Toward realistic long-term neurological gene therapy for chronic diseases. Proc. Natl. Acad. Sci. USA 2000, 97:7482-7487.
17. Umana P., Gerdes C.A., Stone D., Davis J.R., Ward D., Castro M.G., Löwenstein P.R. Efficient FLPe recombinase enables scalable production of helper-dependent adenoviral vectors with negligible helper-virus contamination. Nature Biotechnol. 2001, 19:582-585.